Lifestyle Features

Teva wins FDA approval for monthly schizophrenia injection Weltruza

Reuters  |  Updated Oct. 9 - 11:45 a.m.  |  Save Story

(Corrects sourcing in bullet 3, updates share reaction in ​bullet point 5)

Health Rounds: Blindness treatment based on Nobel-winning research shows promise

Nancy Lapid, Reuters  |  Updated Oct. 9 - 7:49 a.m.  |  Save Story

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble

Reuters  |  Updated Oct. 8 - 2:48 p.m.  |  Save Story

Argenx said on Thursday it had discontinued ​a late-stage study of its efgartigimod drug in adults with Sjögren's disease, an autoimmune ‌condition that damages the glands producing tears and saliva, ⁠putting its shares ​on track for their ⁠biggest one-day fall in almost three ‌years.

Glaukos says late-stage eye disease treatment shows lasting benefits after single dose

Reuters  |  Updated Oct. 8 - 12:19 p.m.  |  Save Story

Glaukos said on Wednesday patients treated with its ​late-stage eye disease therapy maintained improvements in vision and corneal shape three years after a ‌single treatment for keratoconus, a disease that can progressively distort vision.

US FDA flags four deaths in Newron's schizophrenia drug studies

Reuters  |  Updated Oct. 8 - 11:47 a.m.  |  Save Story

Italy's Newron Pharmaceuticals said on Thursday the US FDA had identified four deaths ​among patients treated with its experimental schizophrenia drug in feedback following the agency's earlier decision to place a clinical hold ‌on the treatment's trial in the US.

North Carolina reports first flu death of 2026-27 season

Reuters  |  Updated Oct. 8 - 8:58 a.m.  |  Save Story

North Carolina has reported its first flu death ​of the 2026-2027 season, state health officials said on Thursday, urging residents to get ‌vaccinated against seasonal respiratory illnesses.

Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal

Siddhi Mahatole, Reuters  |  Updated Oct. 8 - 8:38 a.m.  |  Save Story

Drugmaker Viatris said on Thursday it would buy Pacira BioSciences for $1.65 billion in ​cash, adding two non-opioid pain treatments to its portfolio as it looks to build out higher-value branded medicines beyond its core generics business.

Life sciences firm Danaher to launch AI-powered autonomous research lab in 2027

Reuters  |  Updated Oct. 7 - 2:06 p.m.  |  Save Story

Life sciences company Danaher said on Wednesday ​it plans to launch its first AI-powered autonomous research lab early next ‌year to make drug discovery and development faster and more ⁠efficient.

AI companies run virtual drug trials, aim to improve success of human studies

Deena Beasley, Reuters  |  Updated Oct. 7 - 2:05 p.m.  |  Save Story

Novartis' experimental del-desiran for a rare type of muscular dystrophy was expected to be a winner, with the Swiss company's CEO predicting annual peak sales of $5 billion. When a late-stage trial missed its goal last month, shares fell 11%, erasing $30 billion in market ​value.

Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial

Reuters  |  Updated Oct. 7 - 2:01 p.m.  |  Save Story

Zealand Pharma said on Wednesday its experimental drug ​helped people who are overweight or obese and have type 2 diabetes lose up ‌to 9.2% of their body weight in a mid-stage trial. ⁠The Danish company is ​developing it with Roche.

US FDA expands use of Novartis drug for chronic skin condition

Reuters  |  Updated Oct. 7 - 1:44 p.m.  |  Save Story

The US Food and Drug Administration has expanded the use ​of Novartis' drug to treat adults with a chronic skin condition that causes recurring itchy welts, the Swiss ‌drugmaker said on Wednesday.

Pharma lobby sues Trump administration over Medicare drug price cuts

Michael Erman, Reuters  |  Posted Oct. 7 - 11:18 a.m.  |  Save Story

The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's efforts to benchmark U.S. drug prices ​to lower costs overseas in the Medicare health insurance program, arguing that it is an illegal government overreach.

BRIEF

Farmington High School turns food drive into friendly competition

VideoMadi Vollmer, KSL  |  Posted Oct. 7 - 10:26 a.m.  |  Save Story

Students at Farmington High School are competing to collect as much food as possible for Utah families facing food insecurity.

Battle of the Broncs returns to Grantsville with a fight against cancer

VideoMadi Vollmer, KSL  |  Posted Oct. 6 - 1:50 p.m.  |  Save Story

This year's rodeo, "Ride for the Fight," will honor cancer patients, survivors and loved ones while bringing the community together.

Kenya confirms first Ebola case after man who travelled from Congo dies

Reuters  |  Updated Oct. 6 - 1:14 p.m.  |  Save Story

Kenya confirmed its first Ebola case on Tuesday after a Kenyan citizen who had travelled from Democratic Republic of Congo died in Nairobi.

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal

Sneha S K, Reuters  |  Updated Oct. 6 - 10:30 a.m.  |  Save Story

Drug distributor McKesson and private equity firm Clayton Dubilier & Rice on Tuesday ​agreed to take infusion therapy provider Option Care Health private in a deal worth about $5.8 billion including debt.

ArriVent's cancer pill fails to 'meaningfully' delay disease progression, shares dive

Christy Santhosh, Reuters  |  Updated Oct. 6 - 9:06 a.m.  |  Save Story

ArriVent BioPharma said on Tuesday its oral therapy to treat patients ​with a rare type of lung cancer did not significantly delay disease progression in a late-stage trial, sending its shares plunging ‌nearly 60% in morning trading.

No plague cases detected in Siberia, Russia says, and locals play down scare

Reuters  |  Updated Oct. 6 - 7:50 a.m.  |  Save Story

Russia's health watchdog said on Tuesday that no cases of plague had been detected among anyone who had come into contact with ​a Siberian plague institute laboratory worker who died last week, and locals said their lives had barely been disrupted.

Could your charging habits spark a fire? Safety tips from firefighters for Fire Prevention Week

VideoEmma Benson, KSL  |  Updated Oct. 5 - 9:37 p.m.  |  Save Story

Safe charging habits and proper battery disposal can help prevent fires involving everyday devices, firefighters say.